<--- Back to Details
First PageDocument Content
Bacteria / Telithromycin / Pneumococcal conjugate vaccine / Bacterial pneumonia / Macrolide / Amoxicillin / Streptococcus pneumoniae / Pneumococcal vaccine / Community-acquired pneumonia / Pneumonia / Medicine / Biology
Date: 2007-01-16 14:32:20
Bacteria
Telithromycin
Pneumococcal conjugate vaccine
Bacterial pneumonia
Macrolide
Amoxicillin
Streptococcus pneumoniae
Pneumococcal vaccine
Community-acquired pneumonia
Pneumonia
Medicine
Biology

Microsoft PowerPoint - 15_Main CAP Musher_vers1-3.ppt

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 90,29 KB

Share Document on Facebook

Similar Documents

Trabajos Libres 2017 MENINGITIS POR STREPTOCOCCUS PNEUMONIAE EN LA ERA DE LA VACUNACION Título: ANTINEUMOCICCICA: REPORTE DE CASO Autor: PANDURO VALDEZ LI Co-autor: BECERRA TREJO BG; ESPINOZA OLIVA MM

DocID: 1vmc2 - View Document

Ministerio de Salud BOLETÍN VIGILANCIA DE LABORATORIO Vigilancia de Laboratorio de Streptococcus pneumoniae

DocID: 1uREL - View Document

1 Vol. 4, No. 11, NoviembreVigilancia de Enfermedad Invasora Streptococcus pneumoniae. Chile, 2007 – 2014.

DocID: 1uDbc - View Document

Ministerio de Salud VIGILANCIA DE LABORATORIO Comportamiento de Streptococcus pneumoniae serotipos 3 y 19 A en

DocID: 1udYJ - View Document

Pneumonia / Bacteria / Microbiology / Medicine / Pneumococcal pneumonia / Antimicrobial resistance / Streptococcus pneumoniae / Pneumococcal infection / Bacterial pneumonia

LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held

DocID: 1rhtI - View Document